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Abstract
Background: A number of gene expression studies have investigated changes induced by drug
exposure, but few reports describe changes that persist following relapse. In this study, genome-
wide analysis of gene expression was conducted following an extinction session (90 min) in rats that
expressed behavioral incubation of heroin-seeking and goal-directed behavior. As an important
modulator of goal-directed behavior, the medial prefrontal cortex (mPFC) was the target of
genomic analysis. Rats were trained to self-administer heroin during 3 h daily sessions for 14 d.
Following the self-administration period, rats were reintroduced to the self-administration
chambers for a 90-minute extinction session in which they could seek heroin, but received none.
Extinction sessions were conducted on groups after either 1 d or 14 d of drug-free enforced
abstinence to demonstrate behavioral incubation.
Results: Behavioral data demonstrated incubation (increased expression) of heroin-seeking and
goal-directed behavior after the 14 d abstinent period. That is, following 14 d of enforced
abstinence, animals displayed heightened drug-seeking behavior when returned to the environment
where they had previously received heroin. This increased drug-seeking took place despite the fact
that they received no drug during this extinction session. Whole genome gene expression analysis
was performed and results were confirmed by quantitative real-time PCR (RT-qPCR). Microarrays
identified 66 genes whose expression was identified as changed by at least 1.4 fold (p < 0.02)
following 14 d of abstinence and the 90-minute extinction session compared to the saline treated
controls. Orthogonal confirmation by RT-qPCR demonstrated significant alterations in bdnf, calb1,
dusp5, dusp6, egr1, npy, rgs2.
Conclusion: Ontological analysis indicates that several of the genes confirmed to be changed are
important for neuroplasticity, and through that role may impact learning and behavior. The
importance of drug-seeking behavior and memory of previous drug-taking sessions suggest that
such genes may be important for relapse. The global gene expression analysis adds to the
knowledge of heroin-induced changes and further highlights similarities between heroin and other
drugs of abuse.
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Background
The challenge for drug abuse treatment is maintaining
abstinence despite a high propensity for abstinent
patients to relapse to drug use. Although heroin has been
abused for centuries, effective long-term preventions for
heroin-relapse are still needed. Physiological and gene
expression changes that may increase an individual's like-
lihood to relapse are known to exist well into a period of
abstinence [1-5]. Therefore, relapse to drug use is cur-
rently being investigated on both the molecular and
behavioral levels [6-10]. These studies have been aided by
advances in systems biology tools, including large-scale
discovery techniques such as microarrays and proteomics.
These approaches are useful for discovering novel targets
affected by drug abuse and examining hypotheses con-
cerning categories of genes that are affected by drug use
[11,12]. As data on gene expression following relapse
accumulates, the existence of a single "relapse gene" is
becoming increasingly unlikely. Therefore, macroscopic
views of gene expression (pattern identification) will
prove very useful for guiding research into behavioral
phenomena.
Neurobiological, environmental, cue, and stress mecha-
nisms have all been implicated in relapse to drug use. The
intense craving and motivation to seek drug, reported by
humans during withdrawal from drug use, is challenging
to model in animals, but the need for a relapse model
continues to motivate the design of new behavioral proce-
dures. Incubation is a behavioral phenomenon that is
characterized by increased drug seeking following increas-
ing periods of abstinence after the last self-administration
session [13]. Increased drug-seeking has been inferred to
represent the craving that drives humans to relapse
[2,14,15].
The prefrontal cortex is important for decision making
and guiding behavior [16], and the medial prefrontal cor-
tex (mPFC) is known to be especially important for goal-
directed behaviors [17,18]. Because of its role in guiding
goal-directed, drug-seeking behaviors, understanding the
gene expression changes in this region following a period
of abstinence from drug self-administration will be useful
for understanding the neurobiological basis to relapse fol-
lowing a period of drug self-administration. Additionally,
the ventral mPFC is believed to play an essential role for
expression of incubation of cocaine-seeking [19] and rein-
statement of cocaine-seeking [20].
In this study, we performed a whole genome analysis of
gene expression in the medial prefrontal cortex of rats that
displayed incubation of goal-directed behavior following
2 weeks of heroin self-administration and 2 weeks of
home-cage enforced abstinence. After the abstinence
period, rats (drug-naïve control animals and heroin self-
administering test subjects) were reintroduced to the test-
ing chambers for a 90-minute extinction session during
which behavioral responses were recorded. This extinc-
tion session served not only to provide an opportunity to
observe behavioral incubation, but also mimicked a real-
life situation in which environmental cues precipitate
relapse behavior following an extended period of absti-
nence. Following this experience of re-exposure to drug-
associated context and cues, RNA was isolated from the
mPFC for whole genome microarray and qPCR analyses.
Ontological analyses revealed that many of the genes
identified to be changed have the potential to be key com-
ponents to neuroadaptations that exist at the time of
relapse.
Methods
Heroin self-administration
The self-administration and extinction procedures have
been previously described [21,22]. Briefly, rats that self-
administered heroin displayed incubation of heroin-seek-
ing when tested in a 90-minute extinction session that
occurred after 2 weeks of enforced abstinence (see Figure
1). As described in previous work, all rats (those destined
for either 1 day or 14 days of abstinence) initially under-
went a habituation procedure during which they received
water on a spout in the self-administration chambers. Fol-
lowing habituation, the rats self-administered heroin
(0.06 mg/0.2 ml infusion via an in-dwelling jugular cath-
eter) by licking the previously water-associated spout dur-
ing 3 hour sessions that occurred on 14 consecutive days.
Spout-licking has been the operant behavior in previous
drug self-administration studies [23-25]. Two empty
spouts, termed "active" and "inactive" were present in the
self-administration chambers (to demonstrate that the
rats focus on a goal  the heroin-associated "active" spout).
A fixed ratio 10 (FR10) schedule of reinforcement existed,
under which 10 consecutive responses on the active spout
produced an automated injection of heroin. Self-adminis-
tering rats were yoked to rats that received infusions of
saline. That is, the control group was a separate set of ani-
mals that were treated exactly the same, but never received
heroin (they received injections of saline anytime their
matched animal received heroin).
The 14 days of heroin self-administration were followed
by a 90-minute extinction session (in the same environ-
ment in which they had previously received heroin) that
occurred following either 1 day or 14 days of drug-free
enforced abstinence after the final self-administration ses-
sion. During the extinction session, responses on active
and inactive spouts were recorded, but no drug was
administered. Immediately after the extinction sessions,
the rats were sacrificed and brain regions were harvested.
All studies were conducted in accordance with The Penn-
sylvania State University Institutional Animal Care andBMC Neuroscience 2009, 10:95 http://www.biomedcentral.com/1471-2202/10/95
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Use Committee (Protocol #2006-045), strictly adhering
to the Guidelines for the Care and Use of Mammals in
Neuroscience and Behavioral Research. National Research
Council, 2003 National Research Council, Guidelines for
the care and use of mammals in neuroscience and behavioral
research (2003)
Dissection and RNA isolation
Sacrifice and tissue dissection
Immediately following the 90-minute extinction session,
all rats were sedated using Propofol (10 mg/kg, i.v.) and
decapitated within 10 minutes. Brains were rapidly
removed from skulls, placed in pre-chilled phosphate
buffered saline (PBS) and then sectioned in an ice-chilled
ASI brain slicer (ASI Instruments, Warren MI). The section
from Bregma +4.4 to 2.4 mm was cut along the forceps
minor (anterior to the corpus collosum) and the cortex
medial to this cut was collected. This includes the cingu-
late (area Cg1), prelimbic cortex, infralimbic cortex, and
medial orbital cortex. Following dissection, the tissue was
placed in prechilled tubes, immediately frozen on dry ice,
and then stored at -80°C.
RNA isolation
Total cellular RNA was isolated using Tri Reagent (Molec-
ular Research Center Inc., Cincinnati, OH) [26]. Isolated
RNA was further purified using an RNeasy Mini Kit for
RNA clean-up (QIAGEN Sciences, Maryland). RNA quan-
tity and quality were assessed using the RNA 6000 Nano
Assay with an Agilent 2100 Bioanalyzer (Agilent, Palo
Alto, CA).
Microarray analysis
Microarray analyses were performed on samples from rats
that experienced 14 d of abstinence prior to an extinction
session. Studies were performed by the Penn State College
of Medicine Functional Genomics Core Facility on 12
arrays (n = 6 per treatment group: 14 d abstinent self-
administering and yoked saline) according to standard
procedures [27]. Following the manufacturer's protocol of
the Low Input Fluorescent Linear Amplification Kit (Agi-
lent, Santa Clara, CA), 500 ng RNA with the addition of
One-Color Spike Mix was denatured and incubated with
T7 Promoter primer. Synthesis of cDNA followed with the
addition of First-Strand buffer, DTT, dNTP mix, MMLV-RT
and RNase Out and incubation at 40°C for 2 hours. Tran-
scription of the product incorporated the Cyanine 3-CTP
in the Master Mix which includes Transcription buffer,
DTT, NTPs, PEG, RNase Out, pyrophosphatases and T7
RNA Polymerase, with incubation for 2 hours at 40°C.
The resulting cRNA was purified using RNEasy columns
(Qiagen) followed by assessment of purity, concentration
and quality using a NanoDrop ND-1000 (NanoDrop
Technologies, Wilmington, DE 19810) through calcu-
lated yield and Specific Activity. 1.65 μg from each sample
was fragmented, denatured, and then hybridized to Agi-
Behavioral experimental timeline and extinction responding results Figure 1
Behavioral experimental timeline and extinction responding results. Rats self-administered heroin for 2 weeks fol-
lowed by a 90 minute extinction session that occurred either 1 day or 14 days after the final self-administration. session. Goal-
directed behavior was recorded during the extinction sessions. Data represent means ± SEM. * p < 0.001.
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lent 4 × 44 rat whole genome microarray slides for 17
hours at 65°C. Slides were then washed according to pro-
tocol.
Microarrays were scanned with an Axon 4000B scanner
with GenePix4 v4.0 software at a 5 μm resolution and 635
nm with laser power at 100%, PMT voltage at 600 V, focus
position 0 μm, and lines to average = 1. Images were then
imported into Agilent Feature Extraction Software. Initial
quality control (positive and negative controls), exclusion
of manufacturing defects (MSR spots), background sub-
traction was then performed and the results exported to
GeneSpring GX 7.3 (Agilent Technologies). All primary
array data have been deposited to Gene Expression Omni-
bus (accession number GSE13166).
Microarray Data Analysis
Microarray data were normalized following import into
GeneSpring GX 7.3 (Agilent Technologies) by transform-
ing signal values less than 5.0 to an intensity of 5.0. Nor-
malization was done per chip to the 50th percentile, and
per gene to the median. Values were then normalized on
a per gene basis to the control group. Potential differential
expression was determined with a one-way ANOVA (vari-
ances not assumed to be equal), p < 0.02 and filtered for
1.4 fold and greater differences in expression in accord-
ance with standards for microarray analysis [28]. The use
of a combination of statistical and fold-change cutoffs as
opposed to traditional multiple testing corrections (e.g.,
Bonferroni) produce gene lists with the lowest rate of type
I and type II errors [29]. 1.4-fold was chosen as the fold-
change cutoff, as this magnitude change is at the lower
range of changes we find to be confirmable by RT-qPCR.
Array Data for the complete list of 66 genes that were iden-
tified to have changed expression at the p < 0.02 level of
significance is included in Additional File 1. Also included
are fold-changes in expression, accession numbers, and
probe identification information.
RT-qPCR analysis of gene expression
Complimentary DNA synthesis was performed on total
RNA (n = 8 per treatment group: 1 d abstinent self-admin-
istering, 1 d abstinent yoked saline, 14 d abstinent self-
administering and 14 d abstinent yoked saline) using
Superscript III Reverse Transcriptase (Invitrogen,
Carlsbad, CA). The RNA used for RT-qPCR was an aliquot
from the same samples used to generate microarray
probes. Comparisons at both 1 d of abstinence and 14 d
of abstinence were made to gain insights into whether the
expression changes observed after 14 d of abstinence had
existed immediately after drug use and persisted during
extended abstinence or had emerged during extended
abstinence. One μg RNA, 500 ng Oligo (dT), and 10 mM
each dNTP, were incubated for 5 minutes at 65°C and
then chilled on ice for 2 minutes. 5× First Strand Buffer
(250 mM Tris-HCL (pH8.3), 375 mM KCL, and 15 mM
MgCl2), 5 mM DTT (final concentration), 40 U RNa-
seOut, and 200 U Superscript III RT were then added. The
20 μl reaction was incubated for 60 minutes at 50°C fol-
lowed by a final incubation at 70°C for 15 minutes for ter-
mination. The resulting cDNA product was quantified and
20 ng of product was used in each subsequent qPCR reac-
tion.
Quantitative PCR was carried out on a real-time detection
instrument (ABI 7900HT Sequence Detection System) in
384-well optical plates using TaqMan Universal PCR Mas-
ter Mix and Assay on Demand primers and probes
(Applied Biosystems, Foster City, CA) as described previ-
ously [27,30]. Primer/probe sets used are listed in Table 1.
SDS 2.2.2 software and the 2-ΔΔCt analysis method [31]
were used to quantitate relative amounts using β-actin as
an endogenous control.
Ontological, pathway, and network analysis
Ontological analysis used Gene Ontology (GO) categories
to determine processes or functional categories that were
differentially expressed, as described previously [32] using
GeneSpring GX software. This analysis determined the
number of genes in a category present on the array and the
number of expression changes that would be part of that
category by random chance given the number of differen-
tially expressed genes. Ingenuity Pathway Analysis (Inge-
nuity Systems, Redwood City, CA) was used to create a
network from RT-qPCR confirmed gene expression results
from the rats described in this study.
Statistical Analysis
Behavioral data were analyzed by t-tests at each time point
of abstinence (1 d and 14 d). Goal-directed behavior was
determined by subtracting inactive spout responses from
active spout responses. RT-qPCR gene expression values
were evaluated using t-tests between self-administering
and yoked saline rats at each time point of abstinence (1
or 14 d). For both behavioral and gene expression data,
levels of significance were determined with α set at 0.05.
Correlational analyses were performed to determine
whether a correlation between the goal-directed behavior
or active spout responses during the extinction session
and gene expression existed.
Results
Behavior
Rats were allowed to self-administer heroin during 14
days of daily drug access. The average daily heroin intake
for the rats that experienced only 1 day of abstinence prior
to extinction increased from 7.3 ± 0.5 infusions on day 1
to 12.0 ± 2.5 infusions on day 14 of self-administration.
Average daily heroin intake for the group of rats that expe-
rienced 14 days of abstinence prior to extinction increasedBMC Neuroscience 2009, 10:95 http://www.biomedcentral.com/1471-2202/10/95
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from 7.2 ± 0.6 infusions on day 1 to 10.1 ± 3.1 on day 14
of self-administration. When rats were reintroduced to the
self-administration chambers following 1 d or 14 d of
abstinence, incubation of active spout responses was
observed (defined as a significant increase in responses on
the active spout with the progression of time [21]. Goal-
directed behavior also incubated in self-administering rats
and increased from an average of 80.6 +/- 42.5 responses
following 1 day of abstinence to an average of 302.6 +/-
45.9 responses following 14 days of abstinence (Figure 1).
Goal-directed behavior after 14 days of abstinence was
significantly higher in self-administering vs. yoked saline
rats (p < 0.001). Additionally, 14 day abstinent heroin
self-administering rats had higher goal-directed behavior
than self-administering rats with only 1 day of abstinence
(p < 0.01).
Microarray analysis
Signals from 23,670 probes (of the > 41,000 total probes)
were detected as being present on all of the arrays. Filter-
ing the detected genes produced a list of 66 genes that
were identified as being changed by at least 1.4 fold (at the
p < 0.02 level of significance) relative to saline controls
after 14 days of abstinence and a 90-minute extinction
session. A full listing of differentially expressed genes is
provided in Additional File 1.
RT-qPCR Confirmation and Validation
RT-qPCR was performed to confirm expression levels of
genes for which significant differences in expression were
detected by microarrays. Genes were chosen for confirma-
tion analyses based on their ontological classifications
and probable involvement in drug use. Many genes exam-
ined belonged to ontological categories of nervous system
development or behavior. For each gene examined, sam-
ples from self-administering and yoked saline rats from
each of the abstinent period treatment groups (1 day and
14 days) were examined.
Table 1 depicts the 19 genes on which RT-qPCR was per-
formed for this study. Additionally, Nr4a3 was detected
by our arrays to be significantly increased and has been
previously reported to be increased by another laboratory
[33] and EGR1 was confirmed to be changed in our previ-
ous report of gene expression changes [22]. Of the genes
tested in the present study, 6 (bdnf, calb1, dusp5, dusp6,
npy, rgs2) were validated by RT-qPCR to be changed at a
significance level of at least α = 0.05. The other 13 genes
listed in Table 1 were identified by the microarray to have
significant differences in gene expression, but the RT-
qPCR results did not validate expression differences for
these genes. Reasons for why all 19 genes were not
detected as changed by RT-qPCR include the fact that
many of these genes are expressed near the levels of detec-
tion of the array platform. In addition, false positive
results are common to arrays and account for the need to
provide post-hoc confirmations.
Among the genes that were detected by the arrays to be sig-
nificantly changed, and confirmed by RT-qPCR, were
genes that are important for intracellular signaling (Figure
2A). Dual specificity phosphatase 5 (dusp5) and dual spe-
cificity phosphatase 6 (dusp6) expression levels were both
increased by 39% and 24%, respectively, after 14 days of
abstinence, although only dusp6  expression levels were
increased after only 1 day of abstinence. Regulator of G-
Table 1: List of genes examined in this study.
Abbreviation Gene Name Accession # Assay ID
BDNF Brain derived neurotropic factor NM_012513 Rn02531967_s1
Ctnnb1 Catenin, beta 1 NM_053357 Rn00584431_g1
Calb1 Calbindin 1 NM_031984 Rn00583140_m1
Cdkn1b Cyclin-dependent kinase inhibitor 1B NM_031762 Rn00582195_m1
Chka Choline kinase alpha NM_017127 Rn00567492_m1
Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 NM_053698 Rn00586705_m1
Crk v-crk sarcoma virus oncogene homolog NM_019302 Rn00467066_m1
Dusp5 Dual specificity phosphatase 5 NM_133578 Rn00592122_m1
Dusp6 Dual specificity phosphatase 6 NM_053883 Rn00518185_m1
Fmr1 Fragile X mental retardation syndrome 1 homolog NM_052804 Rn00709627_m1
Glud1 Glutamate dehydrogenase 1 NM_012570 Rn00561306_m1
Gria2 Glutamate receptor, ionotropic, AMPA2 NM_017261 Rn00568514_m1
Hif1a Hypoxia inducible factor 1, alpha subunit NM_024359 Rn00577560_m1
Myst2 MYST histone acetyltransferase 2 NM_181081 Rn00710321_m1
Npy Neuropeptide Y NM_012614 Hs00173470_m1
Npy5r Neuropeptide Y receptor Y5 NM_012869 Rn02089867_s1
Slit2 Slit homolog 2 NM_022632 Rn00575268_m1
Rgs2 Regulator of G-protein signaling 2 NM_053453 Rn00584932_m1
Wasl Wiskott-Aldrich syndrome-like (human) NM_001034130 Rn01501132_m1BMC Neuroscience 2009, 10:95 http://www.biomedcentral.com/1471-2202/10/95
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protein signaling 2 (rgs2) expression was increased by
20% following 14 days of abstinence.
Genes for additional intracellular molecules that each can
be linked to physiological changes that occur following
drug use were also confirmed to be significantly changed
(Figure 2B). Brain-derived neurotrophic factor (bdnf) and
calbindin 1 (calb1) both displayed increased expression
levels, by 32% and 21%, respectively, relative to saline
controls. Neuropeptide Y (npy) gene expression (tested
because the array suggested that expression of one of its
receptors  npy5r  was altered) was decreased by 18% at 1
day of abstinence and 20% at 14 days of abstinence.
Ontological, pathway, and network analysis
Analysis of microarray gene expression data by gene
ontology revealed 24 genes that are involved in develop-
mental processes. Of these genes, 4 were confirmed to be
changed by RT-qPCR: bdnf, calb1, dusp6, egr1 and one
(nr4a3) has been previously reported by another group of
researchers [33]. A second ontological category of interest
was behavior, and 17 genes from our list were included in
this category. Among these genes were egr1 and crybb1.
The Ingenuity network analysis revealed that many genes
validated in this study, together with genes previously
reported from these samples to be significantly changed,
can be linked through a hypothetical network that is
involved with behavior, nervous system development and
function, and cellular development (Figure 3). The path-
way depicted in this figure is based on known intermo-
lecular relationships (but not necessarily direct physical
interactions), although whether this entire network of
interactions occurs in vivo remains to be elucidated. All of
the genes in this pathway were determined to be upregu-
lated.
Correlational Analyses
Behavioral data collected during extinction (goal-directed
responses and active spout responses) was used in corre-
lational analyses with gene expression data. Both Pear-
son's and Spearman's correlations were performed
because of the small sample sizes that were not always
normally distributed. When separate correlations were
performed for data from each time point, Pearson's anal-
yses identified a positive correlation between the number
of active spout responses and dusp5 gene expression in rats
that experienced 1 day of abstinence (p = 0.05; r = 0.70,
data not shown). A significant negative correlation
between  dusp5  gene expression and inactive spout
A. Genes involved in regulation of intracellular signaling Figure 2
A. Genes involved in regulation of intracellular sign-
aling. RT-qPCR confirmed gene expression changes in self-
administering compared to yoked saline rats after 1 and 14 
days of abstinence. B. Genes involved in neuronal adaptations 
to behavior. RT-qPCR confirmed gene expression changes in 
self-administering compared to yoked saline rats after 1 and 
14 days of abstinence. In both panels, data represent means ± 
SEM. * p < 0.01, # p < 0.05.
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responses (p < 0.03; r = -0.78) was detected for rats that
experienced 14 days of abstinence by a Spearman's analy-
sis. Combining the data from both abstinent periods
yielded 8 more significant correlations (Table 2).
Discussion
This study provides the first report of whole genome anal-
ysis of mPFC gene expression in rats that have expressed
behavioral incubation and expands our knowledge of
gene expression changes that exist after abstinence and
during the time of relapse liability. The approach of using
a preliminary screen of the entire genome, followed by
rigorous RT-qPCR confirmation of expression changes for
genes likely to be involved in behavior or neuronal
changes has yielded information on genes, such as dusp5
and dusp6, whose role in addiction is only now beginning
to emerge.
The majority of genes that were significantly changed
using the criteria reported in this paper (52 of 66 genes)
had increased expression levels in heroin self-administer-
ing rats when compared to yoked saline following 14 days
of enforced abstinence. Previously, increased gene expres-
sion has been found for opiate receptors in humans that
died from an opiate overdose [34], as well as components
of the cyclic AMP signaling system following opiate use
[35]. The reasons for a disproportionate number of up-
regulated versus down-regulated genes following absti-
nence from heroin self-administration remain to be deter-
mined. However, when gene expression nears the level of
detection of the microarray platform (as many of these
did), it is becomes more difficult to detect down-regula-
tions.
For the genes identified, and confirmed in this study,
there are several potential impacts on behavior. Phos-
phatase genes, such as dusp5  and  dusp6  (MKP-3; MAP
kinase phosphatase-3), encode proteins that have a direct
impact on intracellular signaling. Dusp5  preferentially
dephosphorylates ERK [36,37] and is intranuclear, while
dusp6  is cytoplasmic [38]. MDMA (3,4-methylenedi-
oxymethamphetamine) has been shown to increase
expression of dusp 1, dusp 5, and dusp 14 genes [39], while
methamphetamine treatment increases dusp6 gene expres-
sion in multiple brain regions [40]. Both dusp5 [41] and
dusp6  [42] regulate mitogen-activated protein kinase
(MAPK). Numerous studies have suggested MAPK
involvement in neuroadaptations that occur following
drug use [43-45]. Beyond being affected by mere drug
exposure, MAPK molecules have also been shown to play
a role in morphine tolerance [46] and to be activated fol-
lowing opiate withdrawal [47]. Interestingly, the MAPK
pathway plays a central role in the relationships between
genes that were reported as changed in this study and our
previous study of gene expression (Figure 3; [22]).
Molecules that regulate G-protein coupled receptor
(GPCR) signaling have been shown to be essential for
reinstatement of heroin-seeking behavior [48]. The
observed increase in rgs2 gene expression following 14
days of abstinence and contextual re-exposure may repre-
sent an intracellular signaling change that affects commu-
nication between receptors and transcription factors,
ultimately affecting cellular and organismal physiology. A
GPCR-regulating molecule (AGS3; Activator of G-protein
signaling 3) was shown, through a gene knock-down
approach, to be essential to activating protein kinase A
(PKA) signaling and observing reinstatement of heroin-
seeking [48].
The microarray analysis detected an NPY receptor,
NPY5R, to be significantly increased after 14 days of absti-
nence. While RT-qPCR for npy5r failed to replicate this
change, the gene encoding npy, the ligand for this recep-
tor, was tested by RT-qPCR and found to be changed. npy
gene expression differed from most other genes examined
because it was decreased in rats that had self-administered
heroin, both after 1 and 14 days of abstinence. Although
npy is a neurotransmitter most recognized for its role in
regulating food intake [49], it has been hypothesized that
npy may contribute to the negative motivational state of
withdrawal [50]. Intracerebroventricular administration
of npy has been found to block increased ethanol intake in
rats [50,51], and overexpression of the npy gene, using
Table 2: Correlational analysis results
Pearson Spearman
BDNF Calb1 Dusp5 NPY BDNF Calb1 Dusp5 NPY
Active Spout Responses 0.58 0.10 0.37 -0.20 0.59 0.08 0.42 -0.18
0.02* 0.73 0.18 0.49 0.02* 0.78 0.11 0.52
Goal-Directed Behavior 0.64 0.48 0.61 -0.55 0.65 0.53 0.48 -0.58
0.01* 0.07 0.02* 0.03* 0.009* 0.04* 0.07 0.02*
Goal-directed response and active spout response data from extinction were correlated with RT-qPCR data. Eight significant correlations were 
detected (4 detected by Pearson's analysis and 4 detected by Spearman's analysis). The upper number in each block of the table is the correlation 
coefficient and the lower number in each block of the table is the P value.BMC Neuroscience 2009, 10:95 http://www.biomedcentral.com/1471-2202/10/95
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intra-amygdalar infusions of a viral expression vector,
diminished alcohol intake following longer periods of
abstinence or repeated alcohol withdrawals [52]. In the
present context, intraventricular injections of npy  have
been found to induce heroin-seeking behavior following
extinction sessions [53], suggesting that the decrease in
npy gene expression observed in the present study may be
related to the extinction component of the behavioral test-
ing.
The majority of genes on which RT-qPCR was performed
displayed expression levels significantly different from
saline controls only after 14 days of abstinence (dusp5,
rgs2, bdnf, calb1). This suggests that these changes are
attributable either solely to the extended drug abstinence
or to the combination of extended abstinence and contex-
tual re-exposure. It is documented that exposure to envi-
ronments previously paired with drug administration can
affect gene expression [54-56], so future studies will be
required to discern whether the observed changes in gene
expression after 14 days of abstinence resulted from con-
textual re-exposure, the pharmacological drug abstinence,
or a combination. Correlational analyses detected that
bdnf was significantly correlated with both goal-directed
behavior and active spout responses (Table 2). This obser-
vation supports the proposed importance of bdnf to drug-
seeking behavior [57]. While the study was not originally
powered to conduct individual correlational analyses, the
findings with bdnf suggest that future work may focus on
individual behavior and gene expression.
Several genes whose expression was changed in this study
have also displayed changed expression levels following
several extinction sessions [33]. In the mPFC, there was an
increase in gene expression relative to controls for arc,
homer1a, ania-3, mkp-1, c-fos, egr1, egr2, and nr4a3. homer1,
egr1, and nr4a3 each were detected by the arrays to have
increased expression values of at least 1.4-fold in the cur-
rent study. The repeated extinction sessions in the Koya et
al. study [33] are a major difference from our study that
may contribute to the differences in gene expression
observed between studies. Genes that were changed in
both Koya's study, which included 14 extinction sessions,
and the present study, which included 1 extinction ses-
sion, are genes that apparently exhibit changed expression
following a prolonged abstinence and maintain that
change in expression regardless of the amount of environ-
mental re-exposures.
The identities of the confirmed genes include not only
transcription factors, but also genes for molecules
involved in intracellular signaling and protein binding
(Figure 3). This range of functions (transcription factors,
receptors, ion channels) provides a reminder that drug use
elicits changes in entire intracellular networks. The impor-
tance of changes in gene expression of certain proteins,
such as calb1 or dusp6, to eliciting changed expression of
genes encoding transcription factors, such as egr1 or fos, is
an area for future investigation.
While this microarray analysis has illuminated genes
whose expression is changed immediately following an
extinction session, the gene expression profile that exists
prior to extinction testing has not been examined in this
study. A comparison between the gene expression profile
following abstinence versus the gene expression profile
following abstinence and extinction would address the
question of what expression changes are specifically
induced by the extinction behavior itself. The increased
activity expressed after 14 days of abstinence may, in part,
have been the cause, rather than the result, of observed
gene expression changes. However, such changes would
fall into the category of immediate early changes as the
extinction testing was only 90 minutes in duration. The
value of the present study is that it focuses on a time point
at which the subjects have experienced contextual re-
exposure, a key component for eliciting relapse. This study
has produced data that are relevant not only for future
studies involving heroin, but also for understanding the
molecular underpinnings of incubation of drug-seeking.
Conclusion
We have identified a group of genes whose expression is
significantly changed following abstinence from heroin
self-administration and incubation of heroin-seeking
behavior. Confirmed genes are not limited to genes
encoding transcription factors, but also encompass genes
encoding molecules that are important for regulation of
intracellular signaling. These regulatory molecules may be
effective targets for drug interventions to prevent relapse.
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